| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 214.6K | $11.95M | - | |
| CFO | 123.3K | $6.86M | - | |
| VP | 84.1K | $4.68M | - | |
| VP | 61.0K | $3.40M | - | |
| Dir | 49.4K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2022 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sell | 8,202 | $81.58 | $669,142.62 | -12.2% | -3.0% | +11.4% | |
| Mar 21, 2022 | George Eric Davis65 | EVP, General Counsel | Sell | 6,129 | $81.29 | $498,226.41 | -8.8% | -3.4% | +13.5% | |
| Mar 11, 2022 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 30,000 | $77.69 | $2,330,700.00 | -8.1% | +0.9% | +19.1% | |
| Feb 28, 2022 | Dennis Slamon | Director | Sell | 6,396 | $78.33 | $501,013.27 | -22.8% | -3.8% | +27.5% | |
| Jan 14, 2022 | V Bryan Lawlis53 | Director | Sale+OE | 4,250 | $87.61 | $372,342.50 | -15.1% | -8.1% | +24.9% | |
| Jan 13, 2022 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 10,000 | $88.43 | $884,300.00 | -3.2% | -4.7% | +27.9% | |
| Dec 16, 2021 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 12,000 | $83.70 | $1,004,340.00 | -3.8% | -3.4% | +30.0% | |
| Dec 1, 2021 | Jean Jacques Bienaime68 | Chief Executive Officer | Sell | 1,500 | $87.22 | $130,831.50 | -0.5% | -8.4% | +21.9% | |
| Oct 26, 2021 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sell | 2,739 | $73.60 | $201,590.40 | -4.7% | +17.4% | +25.4% | |
| Aug 2, 2021 | George Eric Davis65 | EVP, General Counsel | Sell | 5,518 | $76.69 | $423,175.42 | -8.6% | +6.0% | +12.0% |